Anthem Biosciences
ANTHEM · Pharma > Pharmaceuticals & Drugs Listing date: July 21, 2025

Stock Price vs Company Growth
1d
0.9%
1w
0.3%
1m
7.2%
3m
3.3%
6m
21.3%
all
11.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 646 0.9%
579
713
Company Overview

Sales
2,011 Cr
Growth: 47.6%
Profit after Tax
526 Cr
Growth: -11.6%
Large Cap
36,290 Cr
P/E: 69.2x
Industry P/E: 27.1x
Fundamentals

Sales (Cr) ₹ 2,011
Growth 47.6%
EBITDA 36.1%
P/S 18.0x
Dividend 0.0%
P/E 69.2x
Book Value ₹ 2
PEG Ratio 1.5x
ROE 469.2%
P/B N/A
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Anthem Biosciences has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. Awards, accreditations, and recognition2023: Received a certificate of recognition as a ‘Four Star Export House’ from the Ministry of Commerce and Industry.
Investors (1)
Followers (1)